Breast Pathology

Dr. Jeffrey Prichard
Jeffrey W. Prichard, DO

Dr. Hongbing Deng

Hongbing Deng, MD, PhD
Dr. Haiyan Liu
Haiyan Liu, MD
 
 
 
 

Led by Dr. Jeffrey Prichard, the Geisinger Medical Laboratories (GML) Breast Pathology Subspecialty Group includes Dr. Hongbing Deng, Dr. Haiyan Liu, Dr. Steven Meschter, Dr. Hong Yin and Dr. Xiahong (Mary) Zhang. They specialize in diseases of the breast, both benign and malignant. They offer comprehensive diagnostic services, including diagnosis of:

  • Ductal carcinoma
  • Fat necrosis
  • Fibroadenomas
  • Fibrocystic disease
  • Lactating adenoma
  • Galactorrhea
  • Hyperplasia
  • Intraductal papilloma
  • Lobular carcinoma
  • Lymph node metastasis
  • Mammary duct ectasia
  • Mastitis
  • Microcalfications
  • Nipple discharge
  • Paget disease
  • Sclerosing adenosis

Sample breast biopsy report

The Geisinger Medical Laboratories Breast Pathology Subspecialists have conducted extensive research in breast cancer, published many articles in peer-reviewed journals, and have presented at national conferences:

Siegelmann-Danieli N, Khandwlwal V, Wood GC, Mainali R, Prichard JW, Murphy TJ, Evans JF, Yumen O, Bernath AM. Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7. 59-66, 2006.

Fisher ER, Anderson S, Dean S, Dabbs D, Fisher B, Siderits R, Prichard JW, J, Pereira T, Geyer C, Wolmark N. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer 103. 164-173, 2005.

Siegelmann-Danieli N, Murphy TJ, Meschter SC, Stein ME, Prichard JW. Primary pure squamous cell carcinoma of the breast . Clin Breast Cancer 6. 270-272, 2005.

Lin F, Shen T, Prichard JW. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens. Diag Cytopathol 33. 376-380, 2005.

Brown RE, Lun M, Prichard JW, Blasick TM, Zhang PL. Morphoproteomic and Pharmacoproteomic Correlates in Hormone-Receptor-Negative Breast Carcinoma Cell Lines. Ann Clin Lab Sci 34. 261-261, 2004.

Liu H, Lin F, Prichard JW. Sensitivity and Specificity of Immunohistochemical (IHC) detection of ER and PR in Breast Carcinoma on Cell Block Cytology by Quantitative Image Analysis (QIA). Abstract. Modern Pathol 19, 284, 2006.

Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Bernath AM. Breast cancer in elderly women: combined effect of tumor features, age, co-morbidities and treatment. Abstract. 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 2005.

Prichard JW. Immunocytochemistry of Hormone Receptors in Breast Cancer. Abstract and Podium Presentation. 126th Meeting of the Association of Clinical Scientists, Amelia Island, FL, May 2006.

How are specimens transported to your laboratory?

Our couriers retrieve and transport specimens from regional physicians' offices, and we provide prepaid Federal Express services for physicians with offices beyond our own courier service area.

How can I get my patients' results?

Reports can be delivered delivered via fax, mail, courier, or via the Internet with GMLlink , our secure web-based application that allows physicians 24/7 access to laboratory reports.

Do you offer a slide consultation service for second opinion?

Yes. Our specialists offer consultative services that provide guidance for additional diagnostic workup, prognostic information, pathogenetic insight, and therapeutic direction. Please forward the slides, previous surgical pathology reports and, if possible, the paraffin blocks, along with the request.

Do you offer slide preparation and technical services?

Yes, Geisinger Medical Laboratories provides histologic preparation and immunohistochemistry in addition to comprehensive diagnostic services.

Do you offer client billing?

GML offers several billing options:

  1. Contracted Client Billing: GML clients will receive monthly itemized invoices for services provided.
  2. Patient Billing: GML can bill the patient directly if complete billing information is provided on the test requisition form at the time the specimen is submitted. If you have arranged for GML to bill directly, please advise the patient to expect a bill from Geisinger Medical Laboratories
  3. Third Party Billing: GML will bill the patient's insurance company directly.

For details about billing options, please see How to...Pay Your Bill.

Dr. Steven Meschter
Steven C. Meschter, MD
Hong Yin MD
H
ong Yin, MD
Dr. Mary Zhang
Xiahong (Mary) Zhang, MD